Search

Michael P. Cohen

Examiner (ID: 9928, Phone: (571)270-7402 , Office: P/1612 )

Most Active Art Unit
1612
Art Unit(s)
1612
Total Applications
956
Issued Applications
513
Pending Applications
126
Abandoned Applications
367

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16391006 [patent_doc_number] => 20200331947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-22 [patent_title] => Methods of Preparing Steviol Glycosides and Uses of the Same [patent_app_type] => utility [patent_app_number] => 16/915932 [patent_app_country] => US [patent_app_date] => 2020-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45521 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16915932 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/915932
Methods of preparing steviol glycosides and uses of the same Jun 28, 2020 Issued
Array ( [id] => 16620069 [patent_doc_number] => 20210038722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => COCHLEATES MADE WITH SOY PHOSPHATIDYLSERINE [patent_app_type] => utility [patent_app_number] => 16/904824 [patent_app_country] => US [patent_app_date] => 2020-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7793 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904824 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/904824
Cochleates made with soy phosphatidylserine Jun 17, 2020 Issued
Array ( [id] => 17988736 [patent_doc_number] => 20220354773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => ROSEBUSH EXTRACT [patent_app_type] => utility [patent_app_number] => 17/622587 [patent_app_country] => US [patent_app_date] => 2020-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7532 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622587 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/622587
ROSEBUSH EXTRACT Jun 17, 2020 Pending
Array ( [id] => 16734486 [patent_doc_number] => 10960107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-30 [patent_title] => Collagen matrix or granulate blend of bone substitute material [patent_app_type] => utility [patent_app_number] => 16/900262 [patent_app_country] => US [patent_app_date] => 2020-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 12458 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900262 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/900262
Collagen matrix or granulate blend of bone substitute material Jun 11, 2020 Issued
Array ( [id] => 17790605 [patent_doc_number] => 20220249696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => TOLEROGENIC ARTIFICIAL ANTIGEN-PRESENTING CELLS [patent_app_type] => utility [patent_app_number] => 17/602932 [patent_app_country] => US [patent_app_date] => 2020-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12896 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602932 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/602932
TOLEROGENIC ARTIFICIAL ANTIGEN-PRESENTING CELLS Jun 11, 2020 Pending
Array ( [id] => 16511420 [patent_doc_number] => 20200390677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-17 [patent_title] => LEAVE-ON ORAL CARE COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/899882 [patent_app_country] => US [patent_app_date] => 2020-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9723 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899882 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/899882
Leave-on oral care compositions Jun 11, 2020 Issued
Array ( [id] => 17790605 [patent_doc_number] => 20220249696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => TOLEROGENIC ARTIFICIAL ANTIGEN-PRESENTING CELLS [patent_app_type] => utility [patent_app_number] => 17/602932 [patent_app_country] => US [patent_app_date] => 2020-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12896 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602932 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/602932
TOLEROGENIC ARTIFICIAL ANTIGEN-PRESENTING CELLS Jun 11, 2020 Pending
Array ( [id] => 17392419 [patent_doc_number] => 11241407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-08 [patent_title] => Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy [patent_app_type] => utility [patent_app_number] => 16/897152 [patent_app_country] => US [patent_app_date] => 2020-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 33555 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16897152 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/897152
Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy Jun 8, 2020 Issued
Array ( [id] => 17775070 [patent_doc_number] => 20220241419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => Highly dispersible zinc phthalocyanine-silica nanotubes and preparation method therefor [patent_app_type] => utility [patent_app_number] => 17/617540 [patent_app_country] => US [patent_app_date] => 2020-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5295 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617540 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/617540
Highly dispersible zinc phthalocyanine-silica nanotubes and preparation method therefor Jun 1, 2020 Pending
Array ( [id] => 17775070 [patent_doc_number] => 20220241419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => Highly dispersible zinc phthalocyanine-silica nanotubes and preparation method therefor [patent_app_type] => utility [patent_app_number] => 17/617540 [patent_app_country] => US [patent_app_date] => 2020-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5295 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617540 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/617540
Highly dispersible zinc phthalocyanine-silica nanotubes and preparation method therefor Jun 1, 2020 Pending
Array ( [id] => 17775070 [patent_doc_number] => 20220241419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => Highly dispersible zinc phthalocyanine-silica nanotubes and preparation method therefor [patent_app_type] => utility [patent_app_number] => 17/617540 [patent_app_country] => US [patent_app_date] => 2020-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5295 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617540 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/617540
Highly dispersible zinc phthalocyanine-silica nanotubes and preparation method therefor Jun 1, 2020 Pending
Array ( [id] => 17727726 [patent_doc_number] => 11384101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-12 [patent_title] => Oral care compositions [patent_app_type] => utility [patent_app_number] => 16/889093 [patent_app_country] => US [patent_app_date] => 2020-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9271 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16889093 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/889093
Oral care compositions May 31, 2020 Issued
Array ( [id] => 16296249 [patent_doc_number] => 20200281972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => COPPER ION COMPOSITIONS AND METHODS OF TREATMENT FOR CONDITIONS CAUSED BY CORONAVIRUS AND INFLUENZA [patent_app_type] => utility [patent_app_number] => 16/881937 [patent_app_country] => US [patent_app_date] => 2020-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20240 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16881937 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/881937
Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza May 21, 2020 Issued
Array ( [id] => 16435552 [patent_doc_number] => 20200352877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => BAKUCHIOL COMPOSITIONS FOR TREATMENT OF POST INFLAMMATORY HYPERPIGMENTATION [patent_app_type] => utility [patent_app_number] => 16/876333 [patent_app_country] => US [patent_app_date] => 2020-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13260 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16876333 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/876333
Bakuchiol compositions for treatment of post inflammatory hyperpigmentation May 17, 2020 Issued
Array ( [id] => 17747416 [patent_doc_number] => 20220225619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => METHOD AND PROCEDURE FOR OBTAINING NATURAL PYRETHRIN MICROBIOCAPSULES WITH HIGH STABILITY [patent_app_type] => utility [patent_app_number] => 17/611865 [patent_app_country] => US [patent_app_date] => 2020-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2453 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611865 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/611865
METHOD AND PROCEDURE FOR OBTAINING NATURAL PYRETHRIN MICROBIOCAPSULES WITH HIGH STABILITY May 17, 2020 Issued
Array ( [id] => 16267399 [patent_doc_number] => 20200268886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => Orally Dissolving Melatonin Formulation With Acidifying Agent That Renders Melatonin Soluble In Saliva [patent_app_type] => utility [patent_app_number] => 15/931029 [patent_app_country] => US [patent_app_date] => 2020-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5537 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931029 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/931029
Orally dissolving melatonin formulation with acidifying agent that renders melatonin soluble in saliva May 12, 2020 Issued
Array ( [id] => 16267400 [patent_doc_number] => 20200268887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => Orally Dissolving Melatonin Formulation With Acidifying Agent That Renders Melatonin Soluble In Saliva [patent_app_type] => utility [patent_app_number] => 15/931135 [patent_app_country] => US [patent_app_date] => 2020-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5537 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931135 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/931135
Orally dissolving melatonin formulation with acidifying agent that renders melatonin soluble in saliva May 12, 2020 Issued
Array ( [id] => 16435524 [patent_doc_number] => 20200352849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => Topical Skin Formulations and Wound Care Products with Integrated CBD Delivery Mechanisms for Skin Rejuvenation, Wound Care and Healing, Pain and Itch Relief, and Scar Prevention and Treatment [patent_app_type] => utility [patent_app_number] => 16/868492 [patent_app_country] => US [patent_app_date] => 2020-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4532 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16868492 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/868492
Topical Skin Formulations and Wound Care Products with Integrated CBD Delivery Mechanisms for Skin Rejuvenation, Wound Care and Healing, Pain and Itch Relief, and Scar Prevention and Treatment May 5, 2020 Abandoned
Array ( [id] => 16389709 [patent_doc_number] => 20200330650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-22 [patent_title] => BIOCOMPATIBLE MOLDED PART [patent_app_type] => utility [patent_app_number] => 16/866395 [patent_app_country] => US [patent_app_date] => 2020-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8175 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866395 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/866395
Biocompatible molded part May 3, 2020 Issued
Array ( [id] => 17748021 [patent_doc_number] => 20220226224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => DEODORANT COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/608648 [patent_app_country] => US [patent_app_date] => 2020-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2410 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17608648 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/608648
Deodorant composition May 3, 2020 Issued
Menu